Hepatitis B vaccine immunogenicity in Kerman 12 months infants

Authors: not saved
Abstract:

Introduction: Infection  with  HBV  is  the  most  common  chronic  viral  infection  and mortality  in  children.  Prevention of this infection with vaccination is vital.  This  study  was  done  to compare  the  antibody  level  in post hepatitis  B vaccination  in  children  with  12 months  age. Materials  and  Methods:This  descriptive  study  was  carreid  out  on healthy  120  children  with  12 months  age  who  had  notinfected  with  hepatitis  B  infection  in,  kerman  Iran  during 2014. gender, body  weight,  birth  weight, gestational  age  were  recorded  for  each  child.  Hepatitis  B  antibody  level  was  measured  with  ELISA method.  Data were  analyzed  using  SPSS-16 . Results: Antibody  level  was  high- protective for  %81.7  of children , low-responders for %13.3 and no-protective level for %13.3 of children in our study.For % 86.9 children over 2500 kg of birth weight the Antibody  level  was  highly protective incoparison with %57.1 of under 2500 kg of birth weight. This  differnce  was significant.Ther was no significantly  corrolated  with  gender,bodyweight,gestational  age  and  Antibody  level.The family history for hepatitis B infection was negetive for all samples. Conclusion:  This  study  showed  that  the  %95 of children have adequate levels of anti-HBs (≥ 10 IU/L) after vaccination.in addition, immune response was higher in normal birth weight children. Introduction: Infection  with  HBV  is  the  most  common  chronic  viral  infection  and mortality  in  children.  Prevention of this infection with vaccination is vital.  This  study  was  done  to compare  the  antibody  level  in post hepatitis  B vaccination  in  children  with  12 months  age. Materials  and  Methods:This  descriptive  study  was  carreid  out  on healthy  120  children  with  12 months  age  who  had  notinfected  with  hepatitis  B  infection  in,  kerman  Iran  during 2014. gender, body  weight,  birth  weight, gestational  age  were  recorded  for  each  child.  Hepatitis  B  antibody  level  was  measured  with  ELISA method.  Data were  analyzed  using  SPSS-16 . Results: Antibody  level  was  high- protective for  %81.7  of children , low-responders for %13.3 and no-protective level for %13.3 of children in our study.For % 86.9 children over 2500 kg of birth weight the Antibody  level  was  highly protective incoparison with %57.1 of under 2500 kg of birth weight. This  differnce  was significant.Ther was no significantly  corrolated  with  gender,bodyweight,gestational  age  and  Antibody  level.The family history for hepatitis B infection was negetive for all samples. Conclusion:  This  study  showed  that  the  %95 of children have adequate levels of anti-HBs (≥ 10 IU/L) after vaccination.in addition, immune response was higher in normal birth weight children.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Immunogenicity of hepatitis B vaccine in preterm infants.

OBJECTIVE To determine the immunogenicity of hepatitis B vaccine in preterm infants when the first dose of vaccine is delayed until hospital discharge. METHODS One hundred two preterm infants (23 to 36 weeks gestational age) born to hepatitis B surface antigen-negative mothers were enrolled. Immunization was initiated just before hospital discharge with subsequent doses 1 and 6 months later. ...

full text

Response to the complete hepatitis B vaccine regimen in infants under 12 months of age: a case series.

OBJECTIVES Describing rates of seroconversion and its associated factors in a series of Brazilian infants following the final dose of the vaccine at 6 months of age. METHODS Peripheral blood samples were collected after the third dose of the vaccine for the detection of anti-hepatitis B surface antibodies among infants of 7-12 months of age. We measured the association between seroconversion ...

full text

Immunogenicity and safety of an indigenously developed DTPw hepatitis B combination vaccine in Indian infants.

OBJECTIVE To evaluate the safety and immunogenicity of an indigenous hepatitis B, diphtheria, tetanus and B. pertussis tetravalent vaccine (Shantetra) in comparison with Tritanrix HBTM in healthy Indian infants. DESIGN Multicentric, randomized, single blind intention-to-treat study with 12-18 weeks of follow up period. SETTING 5 out patient departments at tertiary care referral centers acro...

full text

Hepatitis A seroprevalence among infants aged 12 months in Ankara.

Seroprevalence studies in various age groups contribute to a better understanding of hepatitis A infection and response to hepatitis A immunization. Hepatitis A seroprevalence in 12-month-old infants from Ankara was studied. Among 601 healthy infants, overall hepatitis A seropositivity was found to be 23.5%. There were no gender differences in seropositivity (22.6% for male and 24.5% for female...

full text

STUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS

In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115 infants aged 12-24 months born to HBsAg negative mothers who received three doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked after the third dose of the vaccine, 94.8% of the infants had developed protective...

full text

Safety and immunogenicity of hepatitis B vaccine ButaNG in adults

Recombinant yeast-derived hepatitis B vaccine manufactured by Instituto Butantan was administered in two groups of adult volunteers (I, II) following two different schedules of immunization. In the first trial (10 &mgr;g doses and 0, 1, 3 months vaccination schedule) 106 individuals completed the full immunization program. The results of seroconversion by age group varied from 70 to 100% and th...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 3  issue 4

pages  0- 0

publication date 2017-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023